By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


US WorldMeds, LLC 

4010 Dupont Circle, Suite 700

Louisville  Kentucky  40207  U.S.A.
Phone: 502-893-3235 Fax: 502-893-1835




Company News
US WorldMeds, LLC Release: Louisville Company Plans $1.1 Million Joint Venture Investment 12/11/2015 8:20:18 AM
US WorldMeds, LLC Release: New Clinical Trial To Study The Use Of MYOBLOC® Injections Into The Salivary Glands To Treat Sialorrhea (Drooling) 11/18/2013 9:52:35 AM
US WorldMeds, LLC Receives $15 Million Grant to Launch New Study 6/18/2013 9:37:54 AM
US WorldMeds, LLC Release: New Clinical Trial Investigates APOKYN for Treating Debilitating Morning Akinesia in Parkinson’s Disease Patients 5/13/2013 9:58:07 AM
US WorldMeds, LLC Acquires Solstice Neurosciences, Inc. For $35.7 Million 8/13/2010 8:44:17 AM
US WorldMeds, LLC Announces the Launch of Revonto(TM) (Dantrolene Sodium for Injection) 7/7/2010 11:30:53 AM
US WorldMeds, LLC Completes Phase III Trial of Lofexidine for Treatment of Opiate Withdrawal Symptoms 6/16/2008 9:21:08 AM
US WorldMeds, LLC Completes Development of Instantaneous Reconstitution Dantrolene Sodium for Injection Product 5/8/2008 9:56:17 AM
FDA Initiates Phase III Trial Of Lofexidine For Treatment Of Opiate Withdrawal Symptoms 10/9/2006 12:20:11 PM
Britannia Pharmaceuticals Limited Signs Agreement With US WorldMeds, LLC To Bring First Non-Opiate Drug Addiction Treatment To The U.S.10/19/2005 5:10:48 PM